Refractory Normoblastic Anaemia: A Clinical and Haematological Study of Seven Cases
J. Dacie,Mary D. Smith,J. White,D. Mollin
DOI: https://doi.org/10.1111/j.1365-2141.1959.tb04013.x
1959-01-01
British Journal of Haematology
Abstract:THE term refractory anaemia was introduced by Rhoads and Barker (1938) and Bomford and Rhoads (1941) to describe cases of anaemia in which there was no recognizable underlying systemic or haematological disease and whchproved resistant to all formsof therapy. Shortly afterwards, Davidson, Davis and Innes (1943), excluding cases of leukaeniia, subdivided refractory-anaemia patients into two groups according to whether sternal-marrow aspiration revealed iiormoblastic or megaloblastic erythropoiesis. The subsequent discovery of folic acid has shown that almost all, or perhaps all, of the cases falling into the megaloblastic group respond, at least partially, to treatment with this vitamin. The norinoblastic group, however, remains unexplained and poorly described. Cases of this type, though rare, can be traced back in the earlier literature and were probably identical with some of the cases of so-called ‘pseudo-aplastic anaemia’ (Thompson, Richter and Edsall, 1934; Bomford and Rhoads, 1941). More recently, it has been suggested by Dameshek and Baldini (1958) that some examples, at least, of refractory anaemia are in reality chronic forms of erythraeniic myelosis (erythro-leukaemia or di Guglielmo’s syndrome). In the present paper we describe studies carried out on seven patients, all with refractory anaemia of unknown origin. Their marrows were intensely cellular due to erythroid hyperplasia. In one patient, there were definite, and in several other patients possible, inegaloblastic changes, which could be corrected, as will be shown later, by the administration of folic acid. Basically, however, the type of hyperplasia can only be described as nornioblastic. All the patients had some degree of leucopenia and two had mild thrombocytopenia. The life-span of the patients’ own red cells was slightly diminished in three of the five patients in whom this was studied, but although haeniolysis thus contributed to their anaemia it was clearly only a minor factor. A feature in common has been the finding of numerous excessively large siderotic granules in many of the normoblasts and the presence in the peripheral blood of varying numbers of hypochromic cells amongst a population of orthochromic cells. The patients thus appear to suffer from a defect of erythropoiesis, and possibly of leucopoiesis and thrombopoiesis also, associated to a varying degree with a defect in the synthesis of haemoglobin. The above group of patients, which we shall refer to as having ‘refractory normoblastic anaemia’, appear likely to be suffering from the same fulidamental disorder as that described recently by Bjorkman (1956) under the title ‘Chronic refractory anaemia with sideroblasts in the bone marrow’.